Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04968548 · ClinicalTrials.gov registry record
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
A clinical trial of Lung Cancer, sponsored by Nucleix.
- Active
- Registry status
- 5,000
- Enrollment target
- 20
- Study locations
NCT04968548: Active study of Lung Cancer, sponsored by Nucleix.
NCT04968548 is a study of Lung Cancer that is active but no longer recruiting, run by Nucleix. The registered enrollment target is 5,000 participants, above the 924-participant average among 409 other Lung Cancer trials with a reported enrollment target (441% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04968548, a study of Lung Cancer, is active but no longer recruiting, sponsored by Nucleix.
- ACTIVE NOT RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Primary Outcome
Collect blood to support the development and validation of a multi analyte test for lung cancer screening
Conditions Studied
Interventions
- PROCEDURE Blood collection
Study Locations (20)
North Carolina
- The University of North Carolina - Chapel Hill
- Duke University - Durham
- Durham VA Health Care System - Durham
- W.G. (Bill) Hefner VA Medical Center - Salisbury
- Novant Health Cancer Research - Winston-Salem
Kentucky
- St. Elizabeth Edgewood Hospital - Edgewood
- Norton Cancer Institute - Louisville
- Owensboro Health - Owensboro
Florida
- Orlando Health, Inc. - Orlando
- Sarasota Memorial Hospital - Sarasota
Missouri
- Harry S. Truman Memorial Veterans' Hospital - Columbia
- Washington University in St. Louis - St Louis
New York
- Northwell Health - New Hyde Park
- University of Rochester - Rochester
California
- Scripps Memorial Hospital - Encinitas
Colorado
- Centura Health - Lakewood
Connecticut
- VA Connecticut Healthcare System - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2021-09-17 |
| Est. Completion | 2025-12 |
What the registry record for NCT04968548 still lists
NCT04968548 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 924-participant average among 409 other Lung Cancer trials with a reported enrollment target (441% higher).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Blood collection is the first listed.
NCT04968548 names 20 study sites across 11 states, led by North Carolina, Kentucky, Florida.
Frequently Asked Questions
What is clinical trial NCT04968548 about?
NCT04968548 is a clinical study titled "Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening". This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
What is the current status of trial NCT04968548?
This trial is currently active not recruiting. The enrollment target is 5,000 participants. The study started on 2021-09-17. Estimated completion is 2025-12.
What conditions does trial NCT04968548 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT04968548?
The interventions under investigation include: Blood collection (PROCEDURE).
Who is sponsoring clinical trial NCT04968548?
This trial is sponsored by Nucleix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04968548 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, Florida, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04968548's enrollment target sits among peer trials
5,000 17th of 409 higher than 392 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI